Switching the light on cartilage repair. Osteoarthritis is a leading cause of pain and disability in adults and affects 15 per cent of the Australian population. This project will develop a revolutionary new approach to treat joint disorders using smart materials and stem cells. The novel materials and techniques developed will help Australia maintain its leading edge in biotechnology.
Degradable hollow microspheres for liver cancer treatment. The expected outcome of this multidisciplinary approach is a controlled drug delivery system for the treatment of liver cancer. We aim to increase the understanding of drug release using polymeric microspheres and the influence of the polymer properties on the release kinetics resulting in the tailored drug release for liver cancer treatment. An indepth knowledge in drug delivery can lead to optimised release kinetics leding to an increa ....Degradable hollow microspheres for liver cancer treatment. The expected outcome of this multidisciplinary approach is a controlled drug delivery system for the treatment of liver cancer. We aim to increase the understanding of drug release using polymeric microspheres and the influence of the polymer properties on the release kinetics resulting in the tailored drug release for liver cancer treatment. An indepth knowledge in drug delivery can lead to optimised release kinetics leding to an increased patient convenience and life prolonging treatments.Read moreRead less
Engineering drug transportation behaviour in polymeric gel systems. In collaboration with Seagull Technologies, this project aims to engineer, study and mathematically model ultrasound-assisted biomacromolecule transport behaviour within polymeric gel systems, which may be useful in new drug delivery methods. The intended outcome is a novel set of polymeric gel systems, which can reversibly bind a wide variety of drugs (small molecules, nucleic acid based drugs, proteins), in which drug release ....Engineering drug transportation behaviour in polymeric gel systems. In collaboration with Seagull Technologies, this project aims to engineer, study and mathematically model ultrasound-assisted biomacromolecule transport behaviour within polymeric gel systems, which may be useful in new drug delivery methods. The intended outcome is a novel set of polymeric gel systems, which can reversibly bind a wide variety of drugs (small molecules, nucleic acid based drugs, proteins), in which drug release is triggered by an electric potential and drug transport is controlled by means of sonophoresis. The main advantage of drug delivery via sonophoresis is elimination of risks associated with injections such as infection and damage to local tissue, and elimination of patient discomfort, pain and fear.Read moreRead less
NOVEL TRI-BLOCK CO-POLYMERS FOR CONTROLED RELEASE OF PROTEINS FOR OSTEOGENESIS. This research is being driven by the need for a scaffold for orthopaedic reconstruction that provides controlled release of growth factors to enable rapid healing. None of the current systems possess the required combination of properties to enable new tissue to regenerate rapidly. The aim of this project is to design a system for sustained drug release using block copolymer micelles to encapsulate growth factors and ....NOVEL TRI-BLOCK CO-POLYMERS FOR CONTROLED RELEASE OF PROTEINS FOR OSTEOGENESIS. This research is being driven by the need for a scaffold for orthopaedic reconstruction that provides controlled release of growth factors to enable rapid healing. None of the current systems possess the required combination of properties to enable new tissue to regenerate rapidly. The aim of this project is to design a system for sustained drug release using block copolymer micelles to encapsulate growth factors and then polymerising the micelles in a biodegradable polymer scaffold. This would enable local delivery of osteogenic growth factors to a bone defect.Read moreRead less